Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-23
DOI
10.1038/s41467-019-09221-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel
- (2018) Honglin Jin et al. ACS Nano
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Nanomaterial-Enabled Cancer Therapy
- (2017) Sabina Quader et al. MOLECULAR THERAPY
- Enhancing the Stability and Immunomodulatory Activity of Liposomal Spherical Nucleic Acids through Lipid-Tail DNA Modifications
- (2017) Brian Meckes et al. Small
- Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis
- (2017) Tyler J. Goodwin et al. VACCINE
- A retrospective examination of the US Food and Drug Administration’s clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring
- (2017) Brett Fleisher et al. OncoTargets and Therapy
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Relationships between Poly(ethylene glycol) Modifications on RNA–Spherical Nucleic Acid Conjugates and Cellular Uptake and Circulation Time
- (2016) Alyssa B. Chinen et al. BIOCONJUGATE CHEMISTRY
- Tumor priming using metronomic chemotherapy with neovasculature-targeted, nanoparticulate paclitaxel
- (2016) Xin Luan et al. BIOMATERIALS
- Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach
- (2016) Yao Lu et al. CANCER LETTERS
- MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
- (2016) Peter J.R. Ebert et al. IMMUNITY
- Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer
- (2016) Yang Xiong et al. JOURNAL OF CONTROLLED RELEASE
- Adequately-Sized Nanocarriers Allow Sustained Targeted Drug Delivery to Neointimal Lesions in Rat Arteries
- (2016) Ryosuke Taniguchi et al. MOLECULAR PHARMACEUTICS
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
- (2016) Chunbai He et al. Nature Communications
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
- (2016) Suzanne I.S. Mosely et al. Cancer Immunology Research
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Synthetic Nanoparticles for Vaccines and Immunotherapy
- (2015) Darrell J. Irvine et al. CHEMICAL REVIEWS
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer nanomedicine: addressing the dark side of the enhanced permeability and retention effect
- (2015) Elizabeth Huynh et al. Nanomedicine
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Clinical overview of metronomic chemotherapy in breast cancer
- (2015) Elisabetta Munzone et al. Nature Reviews Clinical Oncology
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
- (2014) Edward A. Sykes et al. ACS Nano
- Curable Patient With Metastatic Colorectal Cancer: Balancing Effective Therapies and Toxicities
- (2014) Katherine Van Loon et al. JOURNAL OF CLINICAL ONCOLOGY
- Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy
- (2014) Demin Liu et al. Nature Communications
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- p53 and Translation Attenuation Regulate Distinct Cell Cycle Checkpoints during Endoplasmic Reticulum (ER) Stress
- (2013) Sally E. Thomas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment
- (2013) Julia Y. Ljubimova et al. JOURNAL OF DRUG TARGETING
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Role of inflammatory dendritic cells in innate and adaptive immunity
- (2012) Cindy Hespel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunochemotherapy against colon cancer by gene transfer of interleukin-12 in combination with oxaliplatin
- (2012) Ruben Hernandez-Alcoceba et al. OncoImmunology
- Melanoma drug wins US approval
- (2011) Heidi Ledford NATURE
- The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
- (2011) Youyou Tu NATURE MEDICINE
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice
- (2010) M. Gonzalez-Aparicio et al. GUT
- Microsatellite instability in colorectal cancer—the stable evidence
- (2010) Eduardo Vilar et al. Nature Reviews Clinical Oncology
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Design considerations for tumour-targeted nanoparticles
- (2009) Hak Soo Choi et al. Nature Nanotechnology
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- FOLFOX and FLOX Regimens for the Adjuvant Treatment of Resected Stage II and III Colon Cancer
- (2008) Saima Sharif et al. CANCER INVESTIGATION
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started